Diabetes Type II, Other Medical Conditions and Pancreatic Cancer Risk: a Prospective Study in The Netherlands

Overview

Journal Br J Cancer

Specialty Oncology

Date 2013 Oct 24

PMID 24149173

Citations 10

Authors

P Eijgenraam

M M Heinen

B A J Verhage

Y C Keulemans

L J Schouten

P A van den Brandt

Affiliations

Soon will be listed here.

Abstract

Background: To date, only a few risk factors for pancreatic cancer have been established. We examined prospectively relations between several medical conditions and pancreatic cancer incidence.

Methods: In 1986, 120 852 participants completed a baseline questionnaire on cancer risk factors, including several self-reported physician diagnosed medical conditions. At baseline, a random subcohort of 5000 participants was selected using a case-cohort approach for analysis. After 16.3 years of follow-up, 448 pancreatic cancer cases (63% microscopically confirmed) were available for analysis.

Results: Diabetes mellitus type II and hepatitis were positively associated with pancreatic cancer risk (multivariable-adjusted hazard ratio: 1.79; 95% confidence interval: 1.12-2.87 and hazard ratio: 1.37; 95% confidence interval: 1.04-1.81, respectively). Furthermore, a positive trend in risk with increasing years of diagnosis of diabetes (P=0.004) and of hepatitis (P=0.02) was observed. However, an inverse association was observed between hypertension and pancreatic cancer risk, this was found among microscopically confirmed cases only (hazard ratio: 0.66; 95% confidence interval: 0.49-0.90), while years since diagnosis of hypertension significantly decreased cancer risk (P for trend=0.02).

Conclusion: In this prospective study, a positive association was observed between self-reported physician diagnosed diabetes mellitus type II and hepatitis and pancreatic cancer risk, whereas an inverse association was observed with hypertension.

Citing Articles

Gallstones, cholecystectomy and the risk of pancreatic cancer: an updated systematic review and meta-analysis of cohort studies.

Sun N, Wang X, Wei J Eur J Gastroenterol Hepatol. 2023; 35(12):1313-1323.

PMID: 37823406 PMC: 10756705. DOI: 10.1097/MEG.0000000000002652.

Dietary Factors and Pancreatic Cancer Risk: An Umbrella Review of Meta-Analyses of Prospective Observational Studies.

Qin X, Chen J, Jia G, Yang Z Adv Nutr. 2023; 14(3):451-464.

PMID: 36849084 PMC: 10201674. DOI: 10.1016/j.advnut.2023.02.004.

Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management.

Jentzsch V, Davis J, Djamgoz M Cancers (Basel). 2020; 12(11).

PMID: 33114159 PMC: 7690843. DOI: 10.3390/cancers12113096.

Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies.

Seretis A, Cividini S, Markozannes G, Tseretopoulou X, Lopez D, Ntzani E Sci Rep. 2019; 9(1):8565.

PMID: 31189941 PMC: 6561976. DOI: 10.1038/s41598-019-45014-4.

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Regev A, Palmer M, Avigan M, Dimick-Santos L, Treem W, Marcinak J Aliment Pharmacol Ther. 2019; 49(6):702-713.

PMID: 30761572 PMC: 6593464. DOI: 10.1111/apt.15153.

References

Lee C, Chang F, Lee S . Risk factors for pancreatic cancer in orientals. J Gastroenterol Hepatol. 1996; 11(5):491-5. DOI: 10.1111/j.1440-1746.1996.tb00296.x. View

Zendehdel K, Nyren O, Ostenson C, Adami H, Ekbom A, Ye W . Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst. 2003; 95(23):1797-800. DOI: 10.1093/jnci/djg105. View

Iloeje U, Yang H, Jen C, Su J, Wang L, You S . Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2009; 30(3):423-9. DOI: 10.1111/j.1478-3231.2009.02147.x. View

Chodick G, Heymann A, Rosenmann L, Green M, Flash S, Porath A . Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control. 2010; 21(6):879-87. DOI: 10.1007/s10552-010-9515-8. View

Grove J, Nomura A, Severson R, STEMMERMANN G . The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol. 1991; 134(9):942-7. DOI: 10.1093/oxfordjournals.aje.a116178. View

Hardt P, Bretz L, Krauss A, Wusten O, Nalop J, Zekorn T . Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis. Dig Dis Sci. 2001; 46(3):536-9. DOI: 10.1023/a:1005690930325. View

Wang F, Gupta S, Holly E . Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev. 2006; 15(8):1458-63. DOI: 10.1158/1055-9965.EPI-06-0188. View

Inoue M, Noda M, Kurahashi N, Iwasaki M, Sasazuki S, Iso H . Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev. 2009; 18(3):240-7. DOI: 10.1097/CEJ.0b013e3283240460. View

Hassan M, Li D, El-Deeb A, Wolff R, Bondy M, Davila M . Association between hepatitis B virus and pancreatic cancer. J Clin Oncol. 2008; 26(28):4557-62. PMC: 2562875. DOI: 10.1200/JCO.2008.17.3526. View

10.

Silverman D . Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen. 2001; 21(1):7-25. DOI: 10.1002/1520-6866(2001)21:1<7::aid-tcm3>3.0.co;2-a. View

11.

Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K . Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer. 2010; 103(11):1644-8. PMC: 2994224. DOI: 10.1038/sj.bjc.6605955. View

12.

Stevens R, Roddam A, Spencer E, Pirie K, Reeves G, Green J . Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer. 2009; 124(10):2400-5. DOI: 10.1002/ijc.24196. View

13.

Greer J, Whitcomb D . Inflammation and pancreatic cancer: an evidence-based review. Curr Opin Pharmacol. 2009; 9(4):411-8. DOI: 10.1016/j.coph.2009.06.011. View

14.

Berger B, Stenstrom G, Sundkvist G . Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care. 1999; 22(5):773-8. DOI: 10.2337/diacare.22.5.773. View

15.

van den Brandt P, Goldbohm R, van t Veer P, Volovics A, Hermus R, Sturmans F . A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol. 1990; 43(3):285-95. DOI: 10.1016/0895-4356(90)90009-e. View

16.

Barlow W, Ichikawa L, ROSNER D, Izumi S . Analysis of case-cohort designs. J Clin Epidemiol. 1999; 52(12):1165-72. DOI: 10.1016/s0895-4356(99)00102-x. View

17.

Batty G, Shipley M, Marmot M, Davey Smith G . Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study. Br J Cancer. 2003; 89(7):1243-7. PMC: 2394304. DOI: 10.1038/sj.bjc.6601255. View

18.

Hassan M, Bondy M, Wolff R, Abbruzzese J, Vauthey J, Pisters P . Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol. 2007; 102(12):2696-707. PMC: 2423805. DOI: 10.1111/j.1572-0241.2007.01510.x. View

19.

Lindgren A, Nissinen A, Tuomilehto J, Pukkala E . Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens. 2005; 19(5):373-9. DOI: 10.1038/sj.jhh.1001834. View

20.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View